CURIS, INC. Revenues
CURIS, INC. (CRIS) reported Revenues of $2.47 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-05-03
- CURIS, INC. revenues for the quarter ending 2018-03-31 was $2.47M, a 15.81% increase year-over-year.
- CURIS, INC. revenues for the quarter ending 2017-12-31 was $3.26M, a 38.10% increase year-over-year.
- CURIS, INC. revenues for the quarter ending 2017-09-30 was $2.44M, a 38.94% increase year-over-year.
- CURIS, INC. revenues for the quarter ending 2017-06-30 was $2.06M, a 22.68% increase year-over-year.
- CURIS, INC. revenues for fiscal 2017 was $9.90M, a 31.50% increase from fiscal 2016.
- CURIS, INC. revenues for fiscal 2016 was $7.53M, a 4.46% decline from fiscal 2015.
- CURIS, INC. revenues for fiscal 2015 was $7.88M, a 19.96% decline from fiscal 2014.
- CURIS, INC. revenues for fiscal 2014 was $9.84M, a 34.39% decline from fiscal 2013.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $2.47M 10-Q · filed 2018-05-03 | $5.73M derived: sum of 2 quarters · filed 2018-05-03 | $8.17M derived: sum of 3 quarters · filed 2018-05-03 | $10.23M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-12-31 | $3.26M 10-K · filed 2018-03-08 | $5.71M derived: sum of 2 quarters · filed 2018-03-08 | $7.77M derived: sum of 3 quarters · filed 2018-03-08 | $9.90M 10-K · filed 2018-03-08 | ||||
| 2017-09-30 | $2.44M 10-K · filed 2018-03-08 | $4.50M derived: sum of 2 quarters · filed 2018-03-08 | $6.64M 10-Q · filed 2017-11-07 | $9.00M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-06-30 | $2.06M 10-K · filed 2018-03-08 | $4.19M 10-Q · filed 2017-08-03 | $6.55M derived: sum of 3 quarters · filed 2018-05-03 | $8.31M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2017-03-31 | $2.13M 10-Q · filed 2018-05-03 | $4.49M derived: sum of 2 quarters · filed 2018-05-03 | $6.25M derived: sum of 3 quarters · filed 2018-05-03 | $7.93M derived: sum of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | $2.36M 10-K · filed 2018-03-08 | $4.12M derived: sum of 2 quarters · filed 2018-03-08 | $5.80M derived: sum of 3 quarters · filed 2018-03-08 | $7.53M 10-K · filed 2018-03-08 | ||||
| 2016-09-30 | $1.76M 10-K · filed 2018-03-08 | $3.44M derived: sum of 2 quarters · filed 2018-03-08 | $5.17M 10-Q · filed 2017-11-07 | $7.26M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-06-30 | $1.68M 10-K · filed 2018-03-08 | $3.41M 10-Q · filed 2017-08-03 | $5.50M derived: sum of 3 quarters · filed 2018-03-08 | $7.54M derived: sum of 4 quarters · filed 2018-03-08 | ||||
| 2016-03-31 | $1.73M 10-K · filed 2018-03-08 | $1.73M 10-Q · filed 2016-05-09 | $3.82M derived: sum of 2 quarters · filed 2018-03-08 | $5.86M derived: sum of 3 quarters · filed 2018-03-08 | $7.95M derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2015-12-31 | $2.09M 10-K · filed 2017-03-09 | $2.09M 10-K · filed 2016-02-29 | $4.14M derived: sum of 2 quarters · filed 2017-03-09 | $6.22M derived: sum of 3 quarters · filed 2017-03-09 | $7.88M 10-K · filed 2018-03-08 | $7.88M 10-K · filed 2016-02-29 | ||
| 2015-09-30 | $2.04M 10-K · filed 2017-03-09 | $2.04M 10-Q · filed 2015-11-09 | $4.13M derived: sum of 2 quarters · filed 2017-03-09 | $5.79M 10-Q · filed 2016-11-03 | $5.79M 10-Q · filed 2015-11-09 | $7.78M derived: sum of 4 quarters · filed 2017-03-09 | ||
| 2015-06-30 | $2.08M 10-K · filed 2017-03-09 | $2.08M 10-Q · filed 2015-08-06 | $3.74M 10-Q · filed 2016-08-04 | $3.74M 10-Q · filed 2015-08-06 | $5.73M derived: sum of 3 quarters · filed 2017-03-09 | $7.50M derived: sum of 4 quarters · filed 2017-03-09 | ||
| 2015-03-31 | $1.66M 10-K · filed 2017-03-09 | $1.66M 10-Q · filed 2015-05-07 | $3.65M derived: sum of 2 quarters · filed 2017-03-09 | $5.42M derived: sum of 3 quarters · filed 2017-03-09 | $10.22M derived: sum of 4 quarters · filed 2017-03-09 | |||
| 2014-12-31 | $1.99M 10-K · filed 2016-02-29 | $3.76M derived: sum of 2 quarters · filed 2016-02-29 | $8.56M derived: sum of 3 quarters · filed 2016-02-29 | $9.84M 10-K · filed 2017-03-09 | $9.84M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | $1.76M 10-K · filed 2016-02-29 | $6.57M derived: sum of 2 quarters · filed 2016-02-29 | $7.85M 10-Q · filed 2015-11-09 | $9.37M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $4.80M 10-K · filed 2016-02-29 | $6.09M 10-Q · filed 2015-08-06 | $7.61M derived: sum of 3 quarters · filed 2016-02-29 | $14.81M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $1.28M 10-K · filed 2016-02-29 | $2.81M derived: sum of 2 quarters · filed 2016-02-29 | $10.01M derived: sum of 3 quarters · filed 2016-02-29 | $15.42M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $1.52M 10-K · filed 2015-02-24 | $8.73M derived: sum of 2 quarters · filed 2015-02-24 | $14.13M derived: sum of 3 quarters · filed 2015-02-24 | $15.00M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $7.20M 10-Q · filed 2014-11-10 | $12.61M derived: sum of 2 quarters · filed 2015-02-24 | $13.48M 10-Q · filed 2014-11-10 | $15.16M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $5.40M 10-K · filed 2015-02-24 | $6.28M 10-Q · filed 2014-08-07 | $7.96M derived: sum of 3 quarters · filed 2015-02-24 | $8.54M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $871.43K 10-K · filed 2015-02-24 | $2.56M derived: sum of 2 quarters · filed 2015-02-24 | $3.14M derived: sum of 3 quarters · filed 2015-02-24 | $7.49M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $1.69M 10-K · filed 2014-03-13 | $2.26M derived: sum of 2 quarters · filed 2014-03-13 | $6.62M derived: sum of 3 quarters · filed 2014-03-13 | $16.97M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $577.76K 10-K · filed 2014-03-13 | $4.93M derived: sum of 2 quarters · filed 2014-03-13 | $15.29M 10-Q · filed 2013-11-12 | $29.37M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $4.35M 10-K · filed 2014-03-13 | $14.71M 10-Q · filed 2013-08-08 | $28.80M derived: sum of 3 quarters · filed 2014-03-13 | $28.94M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | $10.36M 10-K · filed 2014-03-13 | $24.45M derived: sum of 2 quarters · filed 2014-03-13 | $24.59M derived: sum of 3 quarters · filed 2014-03-13 | $24.99M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | $14.09M 10-K · filed 2013-03-13 | $14.24M derived: sum of 2 quarters · filed 2013-03-13 | $14.63M derived: sum of 3 quarters · filed 2013-03-13 | $14.76M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | $147.12K 10-K · filed 2013-03-13 | $539.99K derived: sum of 2 quarters · filed 2013-03-13 | $673.53K 10-Q · filed 2012-11-06 | $773.81K derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-06-30 | $392.87K 10-K · filed 2013-03-13 | $526.40K 10-Q · filed 2012-08-09 | $626.69K derived: sum of 3 quarters · filed 2013-03-13 | $3.87M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2011-03-31 | $133.54K 10-K · filed 2013-03-13 | $233.82K derived: sum of 2 quarters · filed 2013-03-13 | $3.48M derived: sum of 3 quarters · filed 2013-03-13 | $3.57M derived: sum of 4 quarters · filed 2013-03-13 | ||||
| 2010-12-31 | $100.29K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | $3.34M derived: sum of 2 quarters · filed 2013-03-13 | $3.44M derived: sum of 3 quarters · filed 2013-03-13 | $16.00M 10-K · filed 2013-03-13 | ||||
| 2010-09-30 | $3.24M 10-Q · filed 2011-10-31 | $3.34M derived: sum of 2 quarters · filed 2011-10-31 | $15.90M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $98.63K 10-Q · filed 2011-08-04 | $12.66M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | $8.59M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |